https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2012-10-26 / Nutr Res 2012 Nov;32(11):873-83
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2012-10-26 / Nutr Res 2012 Nov;32(11):873-832012-10-26 00:00:002021-06-30 13:46:04Ascorbic acid alleviates toxicity of paclitaxel without interfering with the anticancer efficacy in mice
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2012-10-09 / PLoS One 2012;7(10):e46644
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2012-10-09 / PLoS One 2012;7(10):e466442012-10-09 00:00:002012-10-09 00:00:00Selenoprotein P status correlates to cancer-specific mortality in renal cancer patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2012-10-01 / Immunotherapy 2012 Oct;4(10):995-1009
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2012-10-01 / Immunotherapy 2012 Oct;4(10):995-10092012-10-01 00:00:002019-02-15 08:52:14Dendritic cell-based tumor vaccinations in epithelial ovarian cancer: a systematic review
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2012-10-01 / Immunotherapy 2012 Oct;4(10):1011-22
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2012-10-01 / Immunotherapy 2012 Oct;4(10):1011-222012-10-01 00:00:002019-02-15 08:50:37Dendritic cell-based immunotherapy in mesothelioma
